Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Lipid nanoparticle (LNP) mRNA vaccines emerged during the COVID-19 pandemic to form an almost miraculous protection against a virus, which killed millions around the world. Aided by expedited ...

A groundbreaking approach using mRNA-lipid nanoparticle technology has shown the ability to force HIV out of its latent state ...

Scientists have developed a breakthrough mRNA nanoparticle that forces HIV out of hiding in white blood cells, offering new hope toward a potential functional cure.

The released batch was manufactured at Everest's Jiashan manufacturing site using the Company's proprietary mRNA platform, in compliance with global GMP standards. EVM14 is an off-the-shelf ...

– MT-302 and MT-303 embody the first clinical applications of in vivo mRNA CAR therapies administered systemically – – Initial translational results support proof-of-mechanism with immune ...

– MT-302 and MT-303 embody the first clinical applications of in vivo mRNA CAR therapies administered systemically – – Initial translational results support proof-of-mechanism with immune ...

"Our presentations at ASCO demonstrate the clinical translation of our proprietary mRNA-LNP platform for in vivo immune cell engineering," said Daniel Getts, PhD, CEO and Co-founder of Myeloid ...

– MT-302 and MT-303 embody the first clinical applications of in vivo mRNA CAR therapies administered systemically – – Initial translational results support proof-of-mechanism with immune ...

– MT-302 and MT-303 embody the first clinical applications of in vivo mRNA CAR therapies administered systemically – – Initial translational results support proof-of-mechanism with immune ...